Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 08, 2014 16:01 ET | Source: Chimerix, Inc.

Chimerix Announces Three Abstracts to be Presented at the 2014 World Transplant Congress

DURHAM, N.C., July 8, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the...
June 26, 2014 09:25 ET | Source: Chimerix, Inc.

Chimerix Mourns Passing of Director Rodman L. Drake

DURHAM, N.C., June 26, 2014 (GLOBE NEWSWIRE) -- It is with great sadness that Chimerix, Inc. (Nasdaq:CMRX) marks the death of Director Rodman L. Drake. "We are deeply saddened to learn of Rod's...
June 23, 2014 08:00 ET | Source: Chimerix, Inc.

Chimerix Announces New Directors

DURHAM, N.C., June 23, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the...
June 17, 2014 16:01 ET | Source: Chimerix, Inc.

Chimerix to Present at the JMP Securities Healthcare Conference

DURHAM, N.C., June 17, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that M....
May 27, 2014 16:01 ET | Source: Chimerix, Inc.

Chimerix Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock

DURHAM, N.C., May 27, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the...
May 20, 2014 20:57 ET | Source: Chimerix, Inc.

Chimerix Prices Public Offering of Common Stock

DURHAM, N.C., May 20, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the...
May 19, 2014 16:01 ET | Source: Chimerix, Inc.

Chimerix Announces Commencement of Public Offering of Common Stock

DURHAM, N.C., May 19, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it...
May 16, 2014 08:00 ET | Source: Chimerix, Inc.

Chimerix Regains Worldwide Rights to CMX157

DURHAM, N.C., May 16, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it...
May 09, 2014 07:00 ET | Source: Chimerix, Inc.

Chimerix Announces First Quarter 2014 Financial Results

DURHAM, N.C., May 9, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today reported financial...
May 06, 2014 07:00 ET | Source: Chimerix, Inc.

Chimerix's Brincidofovir (CMX001) Data Accepted for Three Presentations at 27th International Conference on Antiviral Research

DURHAM, N.C., May 6, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced three...